Atlas Trials

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Clinical trial NCT02405364 · COMPLETED

Trial details

NCT number
NCT02405364
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-02-01
Primary completion
2019-11-25
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.